Answer
Setmelanotide should not be administered to patients with hepatic impairment, as it has not been studied in this population.
Sources for this answer
- IMCIVREE 10 mg/ml solution for injectionRhythm Pharmaceutical UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 8Document updated
Sources checked